Innate Pharma S.A. (EPA:IPH)
1.178
+0.022 (1.90%)
Apr 28, 2026, 5:35 PM CET
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
€55,245
Profits / Employee
€301,699
Market Cap
110.53M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MaaT Pharma | 65 |
| Adocia | 77 |
| ABIONYX Pharma | 51 |
| Valerio Therapeutics Société anonyme | 25 |
| OSE Immunotherapeutics | 64 |
| Sensorion | 63 |
| Transgene | 145 |
| Fermentalg | 63 |
Innate Pharma News
- 5 days ago - Innate Pharma to Participate in the D. Boral Capital Global Conference - Business Wire
- 11 days ago - Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026 - Business Wire
- 15 days ago - Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 - Business Wire
- 15 days ago - Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026 - Business Wire
- 20 days ago - Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event - Business Wire
- 25 days ago - Innate Pharma to Participate in the Kempen Life Sciences Conference - Business Wire
- 26 days ago - Innate Pharma Files Its 2025 Universal Registration Document (Document D'enregistrement Universel) and 2025 Form 20-f Annual Report - Business Wire
- 4 weeks ago - Innate Pharma Reports Full Year 2025 Financial Results and Business Update - Business Wire